Pendapatan dodolan perusahaan Liquidia (LQDA)

Liquidia Corp - logo grafis emiten LQDA

Liquidia Corporation focuses on refining drug delivery systems while avoiding mergers. The firm's survival in the pulmonology niche relies on victory in patent wars for the right to release powder inhalers. The GURU.Markets service provides this chart, where the company's operating sales depend on regulatory approvals, and the current parameter equals 0.62, which helps avoid investing at the peak of demand.

LQDA - Pendapatan lan volume dodolan Liquidia Corporation ing rentang 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Liquidia Corp (LQDA)

- rega pasar lan target rega analis:
Ringkesan analisis perusahaan:Liquidia Corporation
Produk seri Liquidia

This metric measures total revenue from product sales, reflecting the business's ability to generate cash flow amid inflationary pressure and interest rate volatility. By analyzing the current sales levels of Liquidia Corporation (LQDA), investors assess the efficiency of asset commercialization, which is critical for Liquidia Corporation (LQDA) due to its high dependence on a single pulmonary hypertension therapy line and the necessity of portfolio diversification.

Pesaing wigati

HLN: Pendapatan dodolan perusahaan|Pendapatan perusahaan Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Jyong Biotech MENS|Ligand Pharma - Pendapatan perusahaan|AMRX - Pendapatan perusahaan|Total pendapatan perusahaan perrigo.com|ALVO (Alvotech SA) - Dodolan perusahaan|GLPG (Galapagos) - Pendapatan perusahaan|Dodolan perusahaan ANIP|Volume dodolan perusahaan MNKD (Afrezza)|Pendapatan lan volume dodolan AMPH|PCRX (Pacira BioSciences) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Pendapatan perusahaan|Aquestive Corp - Pendapatan lan volume dodolan|scpharmaceuticals.com (SCPH) - Dodolan perusahaan|TECX: Pendapatan lan volume dodolan|Tonix Pharmaceuticals - Pendapatan dodolan perusahaan|Dodolan perusahaan SXTC|EPRX: Pendapatan dodolan perusahaan|Dodolan perusahaan BHST (BioHarvest Sciences Inc.)|Pendapatan reged perusahaan Invizyne|Pendapatan perusahaan Oramed Pharmaceuticals ORMP|Pendapatan dodolan perusahaan ENTX|HYFT - Pendapatan perusahaan|Pendapatan dodolan perusahaan ABVC (ABVC BioPharma Inc.)|CPIX: Pendapatan lan volume dodolan|Quantum BioPharma Limited - Pendapatan dodolan perusahaan|FGEN (FibroGen Corp) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Telomir Pharmaceuticals|Pendapatan lan volume dodolan RANI|SNYR (Synergy CHC Corp.) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RLYB (Rallybio Corp)|LEXX: Volume dodolan perusahaan|PULM - Pendapatan perusahaan|PTHL: Pendapatan perusahaan|APM (aptorumgroup.com) - Dodolan perusahaan|Lyra Therapeutics - Pendapatan dodolan perusahaan|Pendapatan perusahaan Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan YCBD|PRFX: Pendapatan tahunan perusahaan|Pendapatan perusahaan altamiratherapeutics.com CYTO|Pendapatan lan volume dodolan Lipella Pharmaceuticals Inc LIPO|OPTN - Pendapatan perusahaan|Pendapatan reged perusahaan Pieris Pharma PIRS|Procaps Group SA (PROC) - Pendapatan perusahaan|Pendapatan tahunan perusahaan PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Pendapatan lan volume dodolan|SLRN: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan TFFP